
News|Articles|April 1, 2002
Zevalin (Ibritumomab tiuxetan)
New biologic: Radioimmunotherapeutic for non-Hodgkin's lymphoma
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement























